{"id":"NCT01877915","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure","officialTitle":"A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Rivaroxaban With Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects With Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-09-10","primaryCompletion":"2018-04-19","completion":"2018-04-19","firstPosted":"2013-06-14","resultsPosted":"2019-05-10","lastUpdate":"2019-05-10"},"enrollment":5081,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Heart Failure","Coronary Artery Disease"],"interventions":[{"type":"DRUG","name":"Rivaroxaban","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"OTHER","name":"Standard of care for heart failure and coronary artery disease","otherNames":[]}],"arms":[{"label":"Rivaroxaban 2.5 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the effectiveness and safety of rivaroxaban compared with placebo (inactive medication), in reducing the risk of death, myocardial infarction or stroke in participants with heart failure and significant coronary artery disease following an episode of decompensated heart failure.","primaryOutcome":{"measure":"Event Rate of All-Cause Mortality, Myocardial Infarction (MI), or Stroke","timeFrame":"Up to Global treatment end date (approximately 54 months)","effectByArm":[{"arm":"Rivaroxaban","deltaMin":13.44,"sd":null},{"arm":"Placebo","deltaMin":14.27,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.270"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":5},"locations":{"siteCount":563,"countries":["United States","Argentina","Australia","Brazil","Bulgaria","Canada","China","Czechia","Denmark","Estonia","France","Germany","Greece","Hungary","Japan","Latvia","Lithuania","Malaysia","Mexico","Netherlands","Poland","Portugal","Romania","Russia","Slovakia","South Africa","South Korea","Spain","Sweden","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["37567750","33686472","33549557","32171760","31461239","31017637","30146935"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":479,"n":2507},"commonTop":["Nasopharyngitis"]}}